NNC0123-0338
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NNC0123-0338, covering 2017-12-08 to 2017-12-08. Get the full timeline:
Most recent: Clinical Trial Update: A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneous NNC0123-0338 in Healthy Subjects and in Subjects With Type 1 Diabetes Mellitus [Phase 1]